Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848224 · ClinicalTrials.gov registry record · NA
Improving Adherence to Pharmacological Treatment
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 689
- Enrollment target
NCT00848224 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 689 participants.
The verdict
NCT00848224, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 689 participants
- Enrollment target
Study Summary
The overall goal of this study was to implement and evaluate the effects of a systems-based and pharmacist-mediated program designed to improve adherence for patients with known coronary heart disease (CHD) to lipid-lowering pharmacologic therapy and of their physicians/nurse practitioners to the National Cholesterol Education Program Guidelines.
Interventions
- BEHAVIORAL systems-based and pharmacist-mediated program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 689 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00848224
The ClinicalTrials.gov registry entry for NCT00848224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 689 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which systems-based and pharmacist-mediated program is the first listed.
NCT00848224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00848224 about?
NCT00848224 is a clinical study titled "Improving Adherence to Pharmacological Treatment". The overall goal of this study was to implement and evaluate the effects of a systems-based and pharmacist-mediated program designed to improve adherence for patients with known coronary heart disease (CHD) to lipid-lowering pharmacologic therapy and of their physicians/nurse practitioners to the Na...
What is the current status of trial NCT00848224?
This trial is currently completed. It is a NA study. The enrollment target is 689 participants. The study started on 2000-09. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00848224?
The interventions under investigation include: systems-based and pharmacist-mediated program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00848224?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.